Cyclophosphamide improves engraftment in patients with SCD and severe organ damage who undergo haploidentical PBSCT

Peripheral blood stem cell transplantation (PBSCT) offers a curative option for sickle cell disease (SCD). Although HLA-matched sibling transplantation is promising, the vast majority of patients lack such a donor. We sought to develop a novel nonmyeloablative HLA-haploidentical PBSCT approach that...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Blood Adv
Autors principals: Fitzhugh, Courtney D., Hsieh, Matthew M., Taylor, Tiffani, Coles, Wynona, Roskom, Katherine, Wilson, Delon, Wright, Elizabeth, Jeffries, Neal, Gamper, Christopher J., Powell, Jonathan, Luznik, Leo, Tisdale, John F.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Hematology 2017
Matèries:
Transplantation
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5727815/
https://ncbi.nlm.nih.gov/pubmed/29296707
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2016002972
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars